Email Alert RSS
Volume 14 Issue 6
Nov.  2023
Turn off MathJax
Article Contents
Abstract
References
Related Articles
WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
Citation: WANG Yongxuan, LI Mei, ZHANG Zhenlin, XIA Weibo. Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(6): 1203-1207. DOI: 10.12290/xhyxzz.2023-0364
shu

Interpretation on the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022)

  • 1.

    Department of Endocrinology, Affiliated Sanming First Hospital, Fujian Medical University, Sanming, Fujian 365000, China

  • 2.

    Department of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Key Laboratory of Endocrinology National Commission of Health, Beijing 100730, China

  • 3.

    Department of Osteoporosis and Bone Disease, the Sixth People's Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai 200233, China

Funds: 

National Key R&D Program of China 2021YFC2501700

National High Level Hospital Clinical Research Funding 2022-PUMCH-D-006

More Information
  • Corresponding author:

    XIA Weibo, E-mail: xiaweibo8301@163.com

  • Received Date: August 06, 2023
  • Accepted Date: August 06, 2023
  • Available Online: September 20, 2023
  • Issue Publish Date: November 29, 2023
    Graphical Abstract
    • Abstract
  • In December 2022, the Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) were released. The guidelines have updated the latest epidemiological data of osteoporosis in China and given recommendations for the diagnosis and treatment of osteoporosis by combining evidence-based medical testimony and clinical practice in this field. This article interprets the key points of the guidelines to help healthcare workers better understand and follow the guidelines.
    • FullText(HTML)
    • References (17)
  • [1]
    Wang O, Hu Y, Gong S, et al. A survey of outcomes and management of patients post fragility fractures in China[J]. Osteoporos Int, 2015, 26: 2631-2640. DOI: 10.1007/s00198-015-3162-6
    [2]
    Hu J, Zheng W, Zhao D, et al. Health-related quality of life in men with osteoporosis: a systematic review and meta-analysis[J]. Endocrine, 2021, 74: 270-280. DOI: 10.1007/s12020-021-02792-0
    [3]
    Wang L, Yu W, Yin X, et al. Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study[J]. JAMA Netw Open, 2021, 4: e2121106. DOI: 10.1001/jamanetworkopen.2021.21106
    [4]
    中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022)[J]. 中华骨质疏松和骨矿盐疾病杂志, 2022, 15: 573-611. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDLS202303004.htm
    [5]
    中国疾病预防控制中心, 中华医学会骨质疏松和骨矿盐疾病分会. 中国骨质疏松症流行病学调查报告(2018)[M]. 北京: 人民卫生出版社, 2021.
    [6]
    Nayak S, Edwards DL, Saleh AA, et al. Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density[J]. Osteoporos Int, 2015, 26: 1543-1554. DOI: 10.1007/s00198-015-3025-1
    [7]
    Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J]. Osteoporos Int, 2019, 30: 3-44. DOI: 10.1007/s00198-018-4704-5
    [8]
    Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using a semiquantitative technique[J]. J Bone Miner Res, 1993, 8: 1137-1148. DOI: 10.1002/jbmr.5650080915
    [9]
    中华医学会骨质疏松和骨矿盐疾病分会. 骨转换生化标志物临床应用指南[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14: 321-336. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS202104001.htm
    [10]
    Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update[J]. Endocr Pract, 2020, 26: 1-46.
    [11]
    Wilkins Parker LR, Preuss CV. Alendronate[M]. Treasure Island (FL): StatPearls Publishing, 2023.
    [12]
    Hirota Y, Nakagawa K, Isomoto K, et al. Eldecalcitol is more effective in promoting osteogenesis than alfacalci-dol in Cyp27b1-knockout mice[J]. PLoS One, 2018, 13: e0199856. DOI: 10.1371/journal.pone.0199856
    [13]
    Food and Drug Administration. Center for drug evaluation and research[EB/OL]. (2020-11-16)[2023-08-04]. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/021318Orig1s054.pdf.
    [14]
    Li N, Cornelissen D, Silverman S, et al. An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis[J]. Pharmacoeconomics, 2021, 39: 181-209. DOI: 10.1007/s40273-020-00965-9
    [15]
    李梅, 章振林, 夏维波. 骨质疏松症药物治疗的必由之路: 长程序贯治疗[J]. 中华骨质疏松和骨矿盐疾病杂志, 2021, 14: 441-446. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS202105001.htm
    [16]
    中华医学会骨质疏松和骨矿盐疾病分会. 骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11: 425-437. https://www.cnki.com.cn/Article/CJFDTOTAL-GUSS201805002.htm
    [17]
    国务院办公厅. 国务院办公厅关于推进分级诊疗制度建设的指导意见[EB/OL]. (2015-09-08)[2023-08-04]. https://www.gov.cn/zhengce/content/2015-09/11/content_10158.htm.
    • Related Articles

  • Related Articles

    [1]LIU Shupeng, YU Mengyang, WU Xiaofei, WANG Hongyun. Clinical Landscape of Therapeutic Cancer Vaccines: Challenges and Opportunities[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1356-1363. DOI: 10.12290/xhyxzz.2024-0130
    [2]LI Jianfeng, ZHANG Jingyi, LI Likang, LIU Yingxin, LI Guowei. Approach to Handling Missing Data in Clinical Trials[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1165-1172. DOI: 10.12290/xhyxzz.2023-0415
    [3]REN Yiming, LI Rui, TANG Si, JI Guanghe, QIN Zelin, ZHAO Leying, TONG Jiaxi, CHEN Yuxuan, GAO Jiaqi, YU Mingkun, RONG Hongguo, XIA Ruyu, FEI Yutong. Public's Knowledge and Experiences Towards Pediatric Clinical Trials: Methodological Characteristics Analysis[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1076-1083. DOI: 10.12290/xhyxzz.2022-0620
    [4]CHEN Chen, HAN Xiaohong. Clinical Trials of Rare Diseases in China over One Decade: Based on the Chinese First List of Rare Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 1028-1035. DOI: 10.12290/xhyxzz.2022-0010
    [5]CHEN Zihan, LI Naishi, LIAN Xiaolan. Coronavirus Disease 2019 and Thyroid Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(3): 487-492. DOI: 10.12290/xhyxzz.2021-0791
    [6]ZHOU Jingya, FAN Junping, ZHANG Meng, ZHOU Jiong. Classification and Coding for Coronavirus Disease 2019 by International Classification ofDiseases: Updates and Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(3): 328-332. DOI: 10.12290/xhyxzz.2021-0236
    [7]DUAN Yan-ping, CAO Jin-ya, WEI Jing, JIANG Jing, ZHAO Xiao-hui, GENG Wen-qi, ZHU Hua-dong. Basic Needs of the First Batch of Medical Staff in the Fever Clinic of Peking Union Medical College Hospital during Coronavirus Disease 2019 Outbreak: A Qualitative Study[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 54-58. DOI: 10.3969/j.issn.1674-9081.2021.01.001
    [8]WANG Shi-rui, CHEN Shi, ZHU Hui-juan. Evaluation and Treatment of Coronavirus Disease 2019 with Obesity[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 13-17. DOI: 10.12290/xhyxzz.20200244
    [9]SUN Xian-song, HOU Xiao-rong, LIU Xiao-ming, ZHOU Bing, CHAI Shuang, HU Ke, QIU Jie, ZHANG Fu-quan. The Experience and Inspiration on the Prevention and Control of Coronavirus Disease 2019 in the Department of Radiotherapy[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 9-12. DOI: 10.12290/xhyxzz.20200242
    [10]PENG Min, SUN Xue-feng, ZHAO Jing, WANG Jing-lan, SONG Lan, WANG Meng-zhao, SHI Ju-hong, LI Tai-sheng, ZHANG Feng-chun, CAI Bai-qiang, ZHU Yuan-jue. Differential Diagnosis between Coronavirus Disease 2019 and Interstitial Pneumonia[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(6): 654-658. DOI: 10.3969/j.issn.1674-9081.2020.06.001

  • Cited by

    Periodical cited type(5)

    1. 王敏，胡兆，徐晓巍，郑思，李姣，姚焰. 融合知识驱动和数据驱动的混合决策模型构建：以室性心动过速病因诊断为例. 协和医学杂志. 2025(02): 454-461 . 本站查看
    2. 吴孟达，毛紫阳，王丹. Shapley值及其应用. 数学建模及其应用. 2024(01): 110-119 .
    3. 李深，唐霁松，曹颖，刘琳，谭魁，万毅，卿竹君，景渝，谢明莉，彭正良. XGBoost模型分析院内心脏骤停患者恢复自主循环的特征. 临床急诊杂志. 2024(11): 579-585 .
    4. 胡冬雪，牛承志，赵春雨，赵丽丽，王鑫. 基于机器学习的ICU多发伤患者发生谵妄预测模型的构建与评估. 中华创伤杂志. 2024(11): 1016-1021 .
    5. 张伟丽，邱晨，宋玉祥，罗云根，宋咪，高远. 机器学习在谵妄风险预测模型构建中的研究进展. 解放军医学院学报. 2023(11): 1292-1296 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views PDF downloads Cited by(7)
    Related
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

      Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return
      x Close Forever Close